Article Text

Download PDFPDF
Clinical utility of pathology data: endometrial and tubo-ovarian carcinomas
  1. Varsha Ishverlal Shah1,
  2. W Glenn McCluggage2
  1. 1 Department of Cellular Pathology, Royal Gwent Hospital, Newport, UK
  2. 2 Department of Pathology, Royal Group of Hospitals and Dental Hospital Health and Social Services Trust, Belfast, UK
  1. Correspondence to Dr Varsha Ishverlal Shah, Department of Cellular Pathology, Royal Gwent Hospital, Newport NP20 2UB, UK; varsha_shah{at}


Cancer resection specimens are usually reported using standardised proformas that consist of a list of elements, which include core (required) and non-core (recommended) items. Although all elements are generally included in the reports, the clinical importance of a particular parameter often depends on a variety of factors, including the clinical setting, local management guidelines and other pathological parameters. In this review, we briefly outline how histopathology data are used to guide management of patients with endometrial and tubo-ovarian cancers, the most common gynaecological malignancies, and provide advice as to which data elements are important in particular scenarios.

  • uterus
  • ovarian neoplasms
  • uterine cervical neoplasms
  • neoplasms

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Handling editor Runjan Chetty.

  • Contributors All authors have contributed equally to this paper.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.